Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Assets Current | ||||||||||
Cash | 3 | 4 | 5 | 6 | 0 | |||||
Prepaid Expense Current | 2 | 4 | 6 | 9 | 0 | |||||
Other Assets Current | - | - | - | - | 1 | |||||
Assets Current | 5 | 8 | 11 | 14 | 1 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 5 | 8 | 12 | 14 | 1 | |||||
Liabilities And Stockhold… | ||||||||||
Liabilities Current | ||||||||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | |||||
Interest Payable Current | - | - | - | - | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | - | 0 | |||||
Long Term Loans Payable | - | - | - | - | 0 | |||||
Liabilities | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | ||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 16 | 16 | 16 | 16 | 1 | |||||
Retained Earnings Accumulated Deficit | -11 | -8 | -5 | -2 | -1 | |||||
Stockholders Equity | 5 | 8 | 11 | 14 | 0 | |||||
Liabilities And Stockholders Equity | 5 | 8 | 12 | 14 | 1 | |||||
Common Stock Shares Authorized | 475 | 475 | 475 | 475 | 475 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Issued | 28 | 28 | 28 | 28 | 24 | |||||
Shares Outstanding | 28 | 28 | 28 | 28 | 24 | |||||
Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Issued | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Outstanding | 1 | 1 | 1 | 1 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.19% | -18.53% | -38.98% | - | - | - | - | - | - | - | - | - |
| 2025 | - | - | - | -90.15% | -91.44% | -93.85% | -12.52% | -27.75% | -46.82% | -10.45% | -31.97% | -42.62% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Curanex Pharmaceuticals Inc (CURX) — SEC Financial Statements & Analysis
Curanex Pharmaceuticals Inc (CURX) is a pharmaceutical preparations company, incorporated in NV. Curanex Pharmaceuticals Inc trades on Nasdaq as: CURX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Curanex Pharmaceuticals Inc reported a Debt-to-Equity ratio of 0.06x, a Price-to-Book (P/B) ratio of 1.57x (TTM), at a market cap of $7.52M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.06x
- P/B TTM
- 1.57x
- Market Cap
- $7.52M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Curanex Pharmaceuticals Inc in?
Curanex Pharmaceuticals Inc (CURX) operates in the Pharmaceutical Preparations industry.
What is CURX's market cap?
Curanex Pharmaceuticals Inc (CURX) has a market capitalization of $7.52M as of 2026-06-30.
What exchange does CURX trade on?
Curanex Pharmaceuticals Inc (CURX) trades on the Nasdaq.
Where is Curanex Pharmaceuticals Inc incorporated?
Curanex Pharmaceuticals Inc is incorporated in NV.